BE1019709A3 - ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION - Google Patents
ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION Download PDFInfo
- Publication number
- BE1019709A3 BE1019709A3 BE2010/0747A BE201000747A BE1019709A3 BE 1019709 A3 BE1019709 A3 BE 1019709A3 BE 2010/0747 A BE2010/0747 A BE 2010/0747A BE 201000747 A BE201000747 A BE 201000747A BE 1019709 A3 BE1019709 A3 BE 1019709A3
- Authority
- BE
- Belgium
- Prior art keywords
- mixture
- calcium
- maltitol
- vitamin
- food product
- Prior art date
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 10
- 239000011707 mineral Substances 0.000 title claims abstract description 10
- 235000013305 food Nutrition 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title claims description 20
- 238000002360 preparation method Methods 0.000 title claims description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims abstract description 17
- 235000010449 maltitol Nutrition 0.000 claims abstract description 17
- 239000000845 maltitol Substances 0.000 claims abstract description 17
- 229940035436 maltitol Drugs 0.000 claims abstract description 17
- 239000011575 calcium Substances 0.000 claims abstract description 14
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 13
- 238000010521 absorption reaction Methods 0.000 claims abstract description 7
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 5
- 210000000981 epithelium Anatomy 0.000 claims abstract description 5
- 210000003692 ilium Anatomy 0.000 claims abstract description 5
- 230000014759 maintenance of location Effects 0.000 claims abstract description 4
- 230000018889 transepithelial transport Effects 0.000 claims abstract description 4
- 230000037182 bone density Effects 0.000 claims abstract description 3
- 230000004936 stimulating effect Effects 0.000 claims abstract description 3
- 230000001737 promoting effect Effects 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 244000299461 Theobroma cacao Species 0.000 claims description 8
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 4
- 229960002061 ergocalciferol Drugs 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 235000019175 phylloquinone Nutrition 0.000 claims description 4
- 239000011772 phylloquinone Substances 0.000 claims description 4
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims description 4
- 229960001898 phytomenadione Drugs 0.000 claims description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 4
- 229960003495 thiamine Drugs 0.000 claims description 4
- 235000001892 vitamin D2 Nutrition 0.000 claims description 4
- 239000011653 vitamin D2 Substances 0.000 claims description 4
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 230000034659 glycolysis Effects 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 claims description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
- 229930024421 Adenine Natural products 0.000 claims description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002211 L-ascorbic acid Substances 0.000 claims description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000005642 Oleic acid Substances 0.000 claims description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 2
- 244000263375 Vanilla tahitensis Species 0.000 claims description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 2
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 229960000643 adenine Drugs 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- 230000037118 bone strength Effects 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 235000019219 chocolate Nutrition 0.000 claims description 2
- -1 cholecalciferol vitamin E tocopherols Chemical class 0.000 claims description 2
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
- 229960003512 nicotinic acid Drugs 0.000 claims description 2
- 235000001968 nicotinic acid Nutrition 0.000 claims description 2
- 239000011664 nicotinic acid Substances 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 229940055726 pantothenic acid Drugs 0.000 claims description 2
- 235000019161 pantothenic acid Nutrition 0.000 claims description 2
- 239000011713 pantothenic acid Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 235000008160 pyridoxine Nutrition 0.000 claims description 2
- 239000011677 pyridoxine Substances 0.000 claims description 2
- 235000020944 retinol Nutrition 0.000 claims description 2
- 239000011607 retinol Substances 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 235000019157 thiamine Nutrition 0.000 claims description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 2
- 239000011721 thiamine Substances 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 235000019149 tocopherols Nutrition 0.000 claims description 2
- 235000019155 vitamin A Nutrition 0.000 claims description 2
- 239000011719 vitamin A Substances 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 235000019143 vitamin K2 Nutrition 0.000 claims description 2
- 239000011728 vitamin K2 Substances 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940011671 vitamin b6 Drugs 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- 229940041603 vitamin k 3 Drugs 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 1
- 229940122361 Bisphosphonate Drugs 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 229920002567 Chondroitin Polymers 0.000 claims 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 235000005979 Citrus limon Nutrition 0.000 claims 1
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 claims 1
- 235000016623 Fragaria vesca Nutrition 0.000 claims 1
- 240000009088 Fragaria x ananassa Species 0.000 claims 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- MPBVHIBUJCELCL-UHFFFAOYSA-N Ibandronate Chemical compound CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O MPBVHIBUJCELCL-UHFFFAOYSA-N 0.000 claims 1
- 235000010254 Jasminum officinale Nutrition 0.000 claims 1
- 240000005385 Jasminum sambac Species 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- 240000008790 Musa x paradisiaca Species 0.000 claims 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 235000019482 Palm oil Nutrition 0.000 claims 1
- 235000019483 Peanut oil Nutrition 0.000 claims 1
- 240000007651 Rubus glaucus Species 0.000 claims 1
- 235000011034 Rubus glaucus Nutrition 0.000 claims 1
- 235000009122 Rubus idaeus Nutrition 0.000 claims 1
- DKJJVAGXPKPDRL-UHFFFAOYSA-N Tiludronic acid Chemical compound OP(O)(=O)C(P(O)(O)=O)SC1=CC=C(Cl)C=C1 DKJJVAGXPKPDRL-UHFFFAOYSA-N 0.000 claims 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 1
- 150000004663 bisphosphonates Chemical class 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 150000001805 chlorine compounds Chemical class 0.000 claims 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims 1
- 235000017803 cinnamon Nutrition 0.000 claims 1
- ACSIXWWBWUQEHA-UHFFFAOYSA-N clodronic acid Chemical compound OP(O)(=O)C(Cl)(Cl)P(O)(O)=O ACSIXWWBWUQEHA-UHFFFAOYSA-N 0.000 claims 1
- 229960002286 clodronic acid Drugs 0.000 claims 1
- 239000003240 coconut oil Substances 0.000 claims 1
- 235000019864 coconut oil Nutrition 0.000 claims 1
- 229940009626 etidronate Drugs 0.000 claims 1
- 239000003925 fat Substances 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- 239000008369 fruit flavor Substances 0.000 claims 1
- 229940050410 gluconate Drugs 0.000 claims 1
- 229960002442 glucosamine Drugs 0.000 claims 1
- 229940015872 ibandronate Drugs 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 229940067606 lecithin Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 239000004006 olive oil Substances 0.000 claims 1
- 235000008390 olive oil Nutrition 0.000 claims 1
- 239000002540 palm oil Substances 0.000 claims 1
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 claims 1
- 229940046231 pamidronate Drugs 0.000 claims 1
- 239000000312 peanut oil Substances 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000008159 sesame oil Substances 0.000 claims 1
- 235000011803 sesame oil Nutrition 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 229940019375 tiludronate Drugs 0.000 claims 1
- 239000000047 product Substances 0.000 description 12
- 239000002253 acid Substances 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 5
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- SVYIZYRTOYHQRE-UHFFFAOYSA-N Vanillactic acid Chemical compound COC1=CC(CC(O)C(O)=O)=CC=C1O SVYIZYRTOYHQRE-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 229940018333 calcium pyruvate Drugs 0.000 description 1
- UZWMCCLZMHPPKW-UHFFFAOYSA-L calcium;2-oxopropanoate Chemical compound [Ca+2].CC(=O)C([O-])=O.CC(=O)C([O-])=O UZWMCCLZMHPPKW-UHFFFAOYSA-L 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical class [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- FFZANLXOAFSSGC-UHFFFAOYSA-N phosphide(1-) Chemical compound [P-] FFZANLXOAFSSGC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
Produit alimentaire organo-minérale, composé de maltitol et d'un complexe de sels de calcium. Le maltitol ayant des effets stimulants sur l'épithélium, optimise le transport trans-épithélial du calcium dans l'ilium, favorisant une meilleure absorption et une meilleure rétention du calcium par l'organisme; aboutissant à une augmentation de la densité osseuse et à une plus grande résistance des os aux fractures.Organo-mineral food product, composed of maltitol and a complex of calcium salts. Maltitol having stimulating effects on the epithelium, optimizes the transepithelial transport of calcium in the ilium, promoting better absorption and better retention of calcium by the body; resulting in increased bone density and greater resistance of the bones to fractures.
Description
DescriptionDescription
Produit alimentaire organo-minéral et procédé de préparation L’objet de l’invention est un procédé de préparation d’un produit alimentaire organo-minéral contenant un sel de calcium et du maltitol. Des études faites avec des mélanges de ces deux produits ont prouvé que le maltitol stimule l’épithélium, optimisant le transport trans-épithélial du calcium dans l’ilium. Ce procédé comprend une étape de mélange et de réchauffement simultané du maltitol et des sels de calcium, une deuxième étape de refroidissement et une troisième étape d’emballage du produit final. Au cours de la première étape, qui est aussi l’étape essentielle de ce procédé, le maltitol et le sel de calcium sont chauffés et mélangés simultanément à une température allant de 90° à 180°C et à des pressions allant de 0,1 jusqu'à 2 bars, pour une durée de chauffe de 10 à 80 minutes. La deuxième étape consiste à transférer le produit vers une tour de refroidissement d'où il est extrait à une température entre 15° et 60°C. La troisième étape consiste à l’emballer. Les avantages majeurs de ce procédé sont : l’augmentation de la productivité et la diminution des coûts de production de plus de 40%, par rapport à la méthode traditionnelle.ORGANO-MINERAL FOOD PRODUCT AND METHOD OF PREPARATION The object of the invention is a process for preparing an organo-mineral food product containing a calcium salt and maltitol. Studies with mixtures of these two products have shown that maltitol stimulates the epithelium, optimizing the transepithelial transport of calcium in the ilium. This process comprises a step of mixing and simultaneous heating of maltitol and calcium salts, a second cooling step and a third step of packaging the final product. During the first step, which is also the essential step of this process, the maltitol and the calcium salt are heated and mixed simultaneously at a temperature ranging from 90 ° to 180 ° C and at pressures ranging from 0.1 up to 2 bar, for a heating time of 10 to 80 minutes. The second step is to transfer the product to a cooling tower where it is extracted at a temperature between 15 ° and 60 ° C. The third step is to pack it. The major advantages of this process are: the increase in productivity and the reduction of production costs by more than 40%, compared to the traditional method.
Le produit résultant de cette mise en œuvre est destiné d’une part à minéraliser et à fortifier les os pendant la croissance et d’autre part à prévenir et à traiter l’ostéoporose. L’avantage majeur du produit final résultant de ce procédé est la création d’un produit organo-minéral dans lequel la fraction organique (le maltitol) stimule l'épithélium et favorise le transport trans-épithélial du calcium dans l’ilium, ce qui résulte en une meilleure absorption et une meilleure rétention du calcium par l’organisme.The product resulting from this implementation is intended on the one hand to mineralize and fortify the bones during growth and on the other hand to prevent and treat osteoporosis. The major advantage of the final product resulting from this process is the creation of an organo-mineral product in which the organic fraction (maltitol) stimulates the epithelium and promotes the trans-epithelial transport of calcium in the ilium. results in better absorption and retention of calcium by the body.
La consommation régulière de ce produit résulte à une densité osseuse plus élevée et à une plus grande résistance des os à la fracture.Regular consumption of this product results in higher bone density and greater bone strength at fracture.
En plus, au cours de la préparation du produit, sous les conditions particulières de ce procédé décrit plus haut, le maltitol est glycolysé sous l’effet de la chaleur produisant de l’acide pyruvique. Cet acide réagit avec le carbonate de calcium pour produire du pyruvate de calcium, un sel organique hautement bio assimilable par l’organisme par rapport au calcium d’origine minérale. De même certaines des autres composantes du hmélange (comme le beurre de cacao, la masse de cacao, le cacao en poudre, la lécithine de soja, la vanille, les acides citrique et lactique) produisent lors de la période de chauffe un nombre d’acides organiques formés soit par hydrolyse soit par glycolysé soit simplement par réaction chimique. Ces acides sont : l’acide propaiioique provenant du chocolat et du cacao, l’acide pyruvique de la glycolyse du maltitol, stéarique, l’acide oléique, l’acide linoléique, l’acide citrique, l’acide lactique et autres suivant la composition et des ingrédients du mélange. De par la présence de ces différents acides, on trouve dans le produit final plusieurs sels organiques de calcium résultant des réactions de ces différents acides sur le sel de carbonate de calcium.In addition, during the preparation of the product, under the particular conditions of this process described above, the maltitol is glycolysed under the effect of heat producing pyruvic acid. This acid reacts with calcium carbonate to produce calcium pyruvate, a highly organic organic salt that can be assimilated by the body compared to calcium of mineral origin. Similarly, some of the other components of the mixture (such as cocoa butter, cocoa mass, cocoa powder, soy lecithin, vanilla, citric and lactic acid) produce during the heating period a number of organic acids formed either by hydrolysis or by glycolysis or simply by chemical reaction. These acids are: propaiioic acid from chocolate and cocoa, pyruvic acid from glycolysis of maltitol, stearic acid, oleic acid, linoleic acid, citric acid, lactic acid and others according to composition and ingredients of the mixture. Because of the presence of these different acids, several organic calcium salts are found in the final product resulting from the reactions of these different acids on the calcium carbonate salt.
Outre ce complexe de sels de calcium et le maltitol, le produit contient aussi des vitamines A rétinol, la vitamine Bl thiamine, B2 riboflavine, B3 niacine, B4 adénine, B5 acide pantothénique, B6 pyridoxine, B 8 biotine, B9 acide folique, B12 cobalamine, la vitamine C acide L ascorbique, la vitamine D2 ergocalciférol, D3 cholécalciférol la vitamine E les tocophérols, la vitamine Kl, phylloquinone, ou sous forme synthétisé, ménaquinone MK2, MK3, MK4, MK5, MK6, MK7, MK8, MK9, MK10. Les vitamines D2, D3, et Kl, K2, MK2 et MK7 ont des effets particuliers. Les vitamines du groupe D favorisent le passage du calcium à travers la paroi intestinale vers le sérum et les vitamines du groupe K activent l’ostéocalcine une protéine osseuse « vitamine K dépendante » qui à pour rôle de fixer et de cristalliser sur elle le cation de calcium et l’anion de phosphore formant des sels d’hydroxyapatite, pour les transporter et les déposer sur l’os.In addition to this complex of calcium salts and maltitol, the product also contains vitamin A retinol, vitamin B1 thiamine, B2 riboflavin, B3 niacin, B4 adenine, B5 pantothenic acid, B6 pyridoxine, B8 biotin, B9 folic acid, B12 cobalamin, vitamin C L ascorbic acid, vitamin D2 ergocalciferol, D3 cholecalciferol vitamin E tocopherols, vitamin K1, phylloquinone, or synthesized form, menaquinone MK2, MK3, MK4, MK5, MK6, MK7, MK8, MK9, MK10. Vitamins D2, D3, and K1, K2, MK2 and MK7 have particular effects. Vitamins in group D promote the passage of calcium through the intestinal wall to the serum and vitamins of group K activate osteocalcin a bone protein "vitamin K dependent" whose role is to fix and crystallize on it the cation of calcium and the phosphorus anion forming hydroxyapatite salts, to transport them and deposit them on the bone.
Des études de bio disponibilité du calcium ont été effectuées avec le produit organo-minéral résultant de la mise en œuvre du procédé décrit plus haut ont démontré que l’absorption du cation de calcium était de 45% à 65% supérieur au taux d’absorption du cation du calcium seul. Il est donc évident que les paramètres particuliers de température, de pression et de temps de contact du produit résultant de ce procédé, aboutissent à un produit organo-minéral unique. En premier lieu la fraction organique composée de maltitol ayant un effet stimulant sur l’épithélium, résulte en une absorption et une diffusion supérieure du cation de calcium (Ca++) dans l’ilium et à une meilleure rétention du cation de calcium par l’organisme. Et en deuxième lieu le complexe de sels calciques organiques contenues dans ce produit organo-minéral sont nettement plus bio disponibles qu’un sel seul. De ce fait le produit est aussi mieux toléré par plus de 80% des personnes ayant une intolérance au calcium.Calcium bioavailability studies were carried out with the organo-mineral product resulting from the implementation of the process described above, demonstrated that the absorption of the calcium cation was 45% to 65% greater than the absorption rate. calcium cation alone. It is therefore obvious that the particular parameters of temperature, pressure and contact time of the product resulting from this process result in a unique organo-mineral product. Firstly, the organic fraction composed of maltitol having a stimulating effect on the epithelium, results in a higher absorption and diffusion of the calcium cation (Ca ++) in the ilium and a better retention of the calcium cation by the organism . And secondly the complex of organic calcium salts contained in this organo-mineral product are significantly more bio available than a single salt. As a result, the product is also better tolerated by over 80% of people with calcium intolerance.
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE2010/0747A BE1019709A3 (en) | 2010-12-22 | 2010-12-22 | ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE201000747 | 2010-12-22 | ||
BE2010/0747A BE1019709A3 (en) | 2010-12-22 | 2010-12-22 | ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION |
Publications (1)
Publication Number | Publication Date |
---|---|
BE1019709A3 true BE1019709A3 (en) | 2012-10-02 |
Family
ID=43646181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2010/0747A BE1019709A3 (en) | 2010-12-22 | 2010-12-22 | ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE1019709A3 (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0343703A2 (en) * | 1988-05-26 | 1989-11-29 | The Procter & Gamble Company | Mineral supplements with sugar alcohols |
JPH06192108A (en) * | 1992-12-25 | 1994-07-12 | Kanebo Ltd | Calcium gluconate oral solution |
WO1998004254A1 (en) * | 1996-07-26 | 1998-02-05 | Beale Paxton K | Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
WO2001047560A2 (en) * | 1999-12-23 | 2001-07-05 | Aventis Animal Nutrition S.A. | Particulate vitamin composition |
EP1426380A1 (en) * | 2001-08-10 | 2004-06-09 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Association compound of trehalose or maltitol with metal ion compound |
EP1652527A1 (en) * | 2003-07-18 | 2006-05-03 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Accelerator for mineral absorption and use thereof |
WO2008011126A2 (en) * | 2006-07-21 | 2008-01-24 | Lyne Laboratories | Liquid compositions of calcium acetate |
JP2008184459A (en) * | 2007-01-31 | 2008-08-14 | Unitika Ltd | Calcium absorption accelerating composition |
WO2010090613A1 (en) * | 2009-02-05 | 2010-08-12 | Mahmut Bilgic | The combined pharmaceutical composition in a single dosage form |
-
2010
- 2010-12-22 BE BE2010/0747A patent/BE1019709A3/en active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0343703A2 (en) * | 1988-05-26 | 1989-11-29 | The Procter & Gamble Company | Mineral supplements with sugar alcohols |
JPH06192108A (en) * | 1992-12-25 | 1994-07-12 | Kanebo Ltd | Calcium gluconate oral solution |
WO1998004254A1 (en) * | 1996-07-26 | 1998-02-05 | Beale Paxton K | Composition of pyruvate and protein and method for increasing protein concentration in a mammal |
WO2001047560A2 (en) * | 1999-12-23 | 2001-07-05 | Aventis Animal Nutrition S.A. | Particulate vitamin composition |
EP1426380A1 (en) * | 2001-08-10 | 2004-06-09 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Association compound of trehalose or maltitol with metal ion compound |
EP1652527A1 (en) * | 2003-07-18 | 2006-05-03 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Accelerator for mineral absorption and use thereof |
WO2008011126A2 (en) * | 2006-07-21 | 2008-01-24 | Lyne Laboratories | Liquid compositions of calcium acetate |
JP2008184459A (en) * | 2007-01-31 | 2008-08-14 | Unitika Ltd | Calcium absorption accelerating composition |
WO2010090613A1 (en) * | 2009-02-05 | 2010-08-12 | Mahmut Bilgic | The combined pharmaceutical composition in a single dosage form |
Non-Patent Citations (1)
Title |
---|
GODA T ET AL: "The maltitol-induced increase in intestinal calcium transport increases the calcium content and breaking force of femoral bone in weanling rats", JOURNAL OF NUTRITION 199811 US, vol. 128, no. 11, November 1998 (1998-11-01), pages 2028 - 2031, XP002647506, ISSN: 0022-3166 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101043823B (en) | Nutritional products having improved quality and methods regarding same | |
RU2383586C1 (en) | Method for production of calcium soaps for animal feeds | |
CN106937742A (en) | The nutrient powder of HMB comprising spray drying | |
CN102726750A (en) | Breakfast sausage and production method thereof | |
CN112369472A (en) | Application of pomfret oil or its extract in preparation of breast milk substitute fat | |
CN1369224A (en) | Method for cooking pressed salted duck | |
UA87265C2 (en) | Process for producing food homogenous solid solvent-free granules containing carotenoids | |
BE1019709A3 (en) | ORGANO-MINERAL FOOD PRODUCT AND PROCESS FOR PREPARATION | |
EP1833314B1 (en) | Infant nutritional kit for regulation of the sleep-wake cycle | |
CN107593920A (en) | A kind of formula milk and its production method for contributing to middle-aged and old sight protectios | |
CA2491167A1 (en) | Use of hesperidin or one of its derivatives for making a medicine for bone formation stimulation | |
CN101690591A (en) | Yak marrow polypeptide bone growing and height increasing tablets (powder) | |
CN102813265A (en) | Functional beverage with ribose and L-carnitine and preparation method thereof | |
CN103082068A (en) | Seafood-flavor peanut crisp candy and preparation method thereof | |
RU2568134C2 (en) | Granulated sugar-containing product with additives and such product manufacture method | |
CN106795540A (en) | CLA rich in rumenic acid | |
CN104782775A (en) | Passiflora-edulia-flavor buffalo milk product | |
CN112335797B (en) | Preparation method of nutritional agent for improving survival rate of immune reconstruction model mice | |
DE10350140A1 (en) | Fruit gum composition | |
RU2533913C1 (en) | Method for fruits and berries complex enrichment with selenium, iodine, zinc, magnesium and manganese | |
RU2766362C1 (en) | Method for production of biologically active additive from germinated wheat seeds | |
RU2583089C1 (en) | Method for production of functional purpose marzipan tiles | |
Lisovaya et al. | Effect of ultrasonic exposure on the efficiency of de-oiling fluid lecithins. | |
RU2160011C1 (en) | Method of producing sugary confectionery | |
RU2611847C1 (en) | Method for preparation of calcium-containing composition from sea urchins shells |